Blue Owl Capital
Entity.
- Evidence
- 36 documents · 22 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 1 Jul 2026, last seen 7 Oct 2026
- Measured
- 8% of mentions say something specific about it; the rest only name it
- As of
- 8 Oct 2026
Where this comes from
- Bisnow · 2026-10-07 · DRA Buys Stake In 1301 Sixth Ave. At $1.3B Valuation: The N.Y. Deal Sheet (opens the source in a new tab)
- Business Model Analyst · 2026-10-07 · ChatGPT’s New Data Center Is Waiting on Gas. The Landlord May Pay (opens the source in a new tab)
- 24/7 Wall St. · 2026-10-06 · The $2 Trillion Private-Credit Market Just Got Some Good News — but Its Biggest Test May Still Be Coming (opens the source in a new tab)
- AZ Big Media Real Estate · 2026-10-06 · 5 biggest commercial real estate deals in Metro Phoenix from September (opens the source in a new tab)
- Bloomberg · 2026-10-02 · Blue Owl Again Caps Two BDCs After 39%, 17% Withdrawal Requests (opens the source in a new tab)
- FinTech Global · 2026-10-01 · US WealthTech deal activity projected to decline 15% in 2026 as investors grow cautious (opens the source in a new tab)
- FreightWaves · 2026-09-30 · Supply Chain Economy: Why Consumer Sentiment is CRASHING Despite Growth (opens the source in a new tab)
- Seoul Economic Daily · 2026-09-28 · U.S. 10-Year Yield Tops 5.2%, 30-Year Hits 5.5% in Era of High Rates (opens the source in a new tab)
- ABF Journal · 2026-09-28 · Middle Market Debt Weekly: October Hike Odds at 70% on a Five-Year-High PMI (opens the source in a new tab)
- Seoul Economic Daily · 2026-09-27 · Trump Rolls Out Red Carpet, Xi Presses Him on Taiwan (opens the source in a new tab)
- MarketBeat News Feed · 2026-09-26 · Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Stock Has Consensus Price Target of $34.58 According to Analysts (opens the source in a new tab)
- SEC EDGAR · 2026-07-01 · 8-K - Blue Owl Capital Corp (0001655888) (Filer) (opens the source in a new tab)